ストックスクリーナーアプリを入手
1.73
0.58%
0.01
プレマーケット:
1.70
-0.03
-1.73%
Filana Therapeutics Inc (FLNA) 最新ニュース
Issuance/retirement of stock (net) of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
FLNA Stock Price, News & Analysis - Stock Titan
Filana Therapeutics, Inc. (FLNA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Capital expenditures of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Free cash flow per share of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
FLNA Should I Buy - Intellectia AI
Price to book ratio of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc. Balance Sheet – NASDAQ:FLNA - TradingView
Long term debt to total equity ratio of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
EBIT of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Number of shareholders of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | FLNA * | US14817C1071 - marketscreener.com
Filana Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | PX91 | US14817C1071 - marketscreener.com
Changes in working capital of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | FLNA | US14817C1071 - marketscreener.com
Non-controlling/minority interest of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Taxes of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
FLNA Technical Analysis & Stock Price Forecast - Intellectia AI
Filana Therapeutics (FLNA) Stock Analysis Report | Financials & Insights - Benzinga
Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - marketscreener.com
Cassava Sciences, Inc. Class Action: The Gross Law Firm Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - marketscreener.com
Filana Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | PX91 | US14817C1071 - marketscreener.com
Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your RightsSAVA - marketscreener.com
Filana Therapeutics Inc (FLNA-Q) Profile - The Globe and Mail
Filana Therapeutics Inc FLNA-Q Earnings - The Globe and Mail
Filana Therapeutics Inc (FLNA-Q) Insider Trade Summaries - The Globe and Mail
Filana Therapeutics Inc (FLNA-Q) Statistics - The Globe and Mail
Net income before discontinued operations of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Total liabilities & shareholders' equities of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Cassava Sciences, Inc. Class Action: Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - marketscreener.com
Filana Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | SAVA * | US14817C1071 - marketscreener.com
Filana Therapeutics, Inc. Statistics – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc.: Financial Data Forecasts Estimates and Expectations | SAVA * | US14817C1071 - marketscreener.com
Total liabilities of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Total liabilities & shareholders' equities of Filana Therapeutics, Inc. – BOATS:FLNA - TradingView
Return on assets % of Filana Therapeutics, Inc. – BOATS:FLNA - TradingView
After tax other income/expense of Filana Therapeutics, Inc. – BOATS:FLNA - TradingView
FLNA Forecast — Price Target — Prediction for 2027 - TradingView
Non-controlling/minority interest of Filana Therapeutics, Inc. – BOATS:FLNA - TradingView
Filana Therapeutics, Inc. Income Statement – BOATS:FLNA - TradingView
EBIT per share of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc.: Top Mutual Funds Holders | FLNA | US14817C1071 - marketscreener.com
Filana Therapeutics, Inc.: Revenue and Earnings Analysts Forecasts Revisions | FLNA | US14817C1071 - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
FLNA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Net debt of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
FLNA PE Ratio & Valuation, Is FLNA Overvalued - Intellectia AI
Filana Therapeutics (NASDAQ: SAVA) pivots to TSC epilepsy amid FDA clinical hold - Stock Titan
Free cash flow of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Cash from investing activities of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
CapEx per share of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Enterprise value of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Return on equity % of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Tangible book value per share of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Price to sales ratio of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Asset turnover of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Enterprise value to EBITDA ratio of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Operating cash flow per share of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Long term debt to total assets ratio of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Working capital per share of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Operating income of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Total debt of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics reports Q4 EPS (26c) vs. (57c) last year - TipRanks
Operating margin % of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Diluted earnings per share (diluted EPS) of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
0.49%
1.47%
大文字化:
|
ボリューム (24 時間):